STAT· @statnews · X·· 23 小时前精选AI 评分65
AI 导读
UniQure报告称，其亨廷顿病基因疗法植入患者脑内四年后仍在延缓疾病进展。不过与一年前的类似分析相比，该疗法获益的幅度有所减弱。
推荐理由
四年随访数据显示该基因疗法仍在延缓亨廷顿病进展，但获益幅度较一年前分析有所减弱。
正文
UniQure's gene therapy for Huntington’s disease continued to slow disease progression four years after its implantation into patients' brains, the company reported.
However, the magnitude of the treatment’s benefit waned compared to a similar analysis conducted one year ago. https://bit.ly/3VH5Njv
来源：STAT · x.com